Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 2,736,000 | 2,477,800 | 2,279,399 | 2,534,700 | 2,645,500 |
| Cost of Goods | 776,900 | 661,000 | 495,500 | 674,400 | 605,000 |
| Gross Profit | 1,959,100 | 1,816,800 | 1,783,900 | 1,860,300 | 2,040,500 |
| Operating Expenses | 1,809,100 | 1,419,400 | 1,686,000 | 1,269,300 | 1,247,800 |
| Operating Income | 150,900 | 397,400 | 98,400 | 591,400 | 792,700 |
| Other Income | -18,500 | -19,700 | -154,400 | -34,100 | -48,700 |
| Pre-tax Income | 132,400 | 377,700 | -56,000 | 557,300 | 744,000 |
| Income Tax | 34,900 | 58,200 | -7,100 | 90,800 | 109,200 |
| Net Income Continuous | 97,500 | 319,500 | -48,900 | 466,500 | 634,800 |
| Net Income | $97,500 | $319,500 | $-48,900 | $466,500 | $634,800 |
| EPS Basic Total Ops | 0.66 | 2.17 | -0.33 | 3.18 | 4.33 |
| EPS Basic Continuous Ops | 0.66 | 2.17 | -0.34 | 3.18 | 4.33 |
| EPS Diluted Total Ops | 0.66 | 2.15 | -0.35 | 3.17 | 4.33 |
| EPS Diluted Continuous Ops | 0.66 | 2.15 | -0.35 | 3.17 | 4.33 |
| EPS Diluted Before Non-Recurring Items | N/A | 3.57 | 1.99 | 4.81 | 5.47 |
| EBITDA(a) | $N/A | $709,400 | $423,400 | $855,100 | $1,043,000 |